NYSE:HQH

Tekla Healthcare Investors Competitors

$24.34
+0.16 (+0.66 %)
(As of 04/14/2021 04:15 PM ET)
Add
Compare
Today's Range
$24.30
Now: $24.34
$24.67
50-Day Range
$22.80
MA: $24.25
$25.84
52-Week Range
$18.68
Now: $24.34
$26.01
Volume126,341 shs
Average Volume155,048 shs
Market Capitalization$1.03 billion
P/E RatioN/A
Dividend Yield7.84%
Beta1.11

Competitors

Tekla Healthcare Investors (NYSE:HQH) Vs. DNP, NUV, ADX, PTY, GSBD, and HTGC

Should you be buying HQH stock or one of its competitors? Companies in the industry of "investment offices, not elsewhere classified" are considered alternatives and competitors to Tekla Healthcare Investors, including DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate & Income Opportunity Fund (PTY), Goldman Sachs BDC (GSBD), and Hercules Capital (HTGC).

Tekla Healthcare Investors (NYSE:HQH) and DNP Select Income Fund (NYSE:DNP) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Dividends

Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. DNP Select Income Fund pays an annual dividend of $0.78 per share and has a dividend yield of 7.7%. Tekla Healthcare Investors has raised its dividend for 1 consecutive years and DNP Select Income Fund has raised its dividend for 1 consecutive years.

Volatility & Risk

Tekla Healthcare Investors has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, DNP Select Income Fund has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500.

Profitability

This table compares Tekla Healthcare Investors and DNP Select Income Fund's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tekla Healthcare InvestorsN/AN/AN/A
DNP Select Income FundN/AN/AN/A

Earnings and Valuation

This table compares Tekla Healthcare Investors and DNP Select Income Fund's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A
DNP Select Income FundN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tekla Healthcare Investors and DNP Select Income Fund, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tekla Healthcare Investors0000N/A
DNP Select Income Fund0000N/A

Insider & Institutional Ownership

22.2% of Tekla Healthcare Investors shares are held by institutional investors. Comparatively, 5.7% of DNP Select Income Fund shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Comparatively, 0.1% of DNP Select Income Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Tekla Healthcare Investors beats DNP Select Income Fund on 4 of the 4 factors compared between the two stocks.

Tekla Healthcare Investors (NYSE:HQH) and Nuveen Municipal Value Fund (NYSE:NUV) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Insider & Institutional Ownership

22.2% of Tekla Healthcare Investors shares are held by institutional investors. Comparatively, 12.7% of Nuveen Municipal Value Fund shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Comparatively, 1.0% of Nuveen Municipal Value Fund shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Tekla Healthcare Investors has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Nuveen Municipal Value Fund has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tekla Healthcare Investors and Nuveen Municipal Value Fund, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tekla Healthcare Investors0000N/A
Nuveen Municipal Value Fund0000N/A

Dividends

Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Nuveen Municipal Value Fund pays an annual dividend of $0.37 per share and has a dividend yield of 3.3%. Tekla Healthcare Investors has raised its dividend for 1 consecutive years and Nuveen Municipal Value Fund has raised its dividend for 1 consecutive years.

Earnings and Valuation

This table compares Tekla Healthcare Investors and Nuveen Municipal Value Fund's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A
Nuveen Municipal Value FundN/AN/AN/AN/AN/A

Profitability

This table compares Tekla Healthcare Investors and Nuveen Municipal Value Fund's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tekla Healthcare InvestorsN/AN/AN/A
Nuveen Municipal Value FundN/AN/AN/A

Summary

Tekla Healthcare Investors beats Nuveen Municipal Value Fund on 4 of the 4 factors compared between the two stocks.

Adams Diversified Equity Fund (NYSE:ADX) and Tekla Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Insider & Institutional Ownership

14.9% of Adams Diversified Equity Fund shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 0.2% of Adams Diversified Equity Fund shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Adams Diversified Equity Fund has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for Adams Diversified Equity Fund and Tekla Healthcare Investors, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Adams Diversified Equity Fund0000N/A
Tekla Healthcare Investors0000N/A

Dividends

Adams Diversified Equity Fund pays an annual dividend of $1.03 per share and has a dividend yield of 5.4%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Adams Diversified Equity Fund has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Valuation and Earnings

This table compares Adams Diversified Equity Fund and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adams Diversified Equity FundN/AN/AN/AN/AN/A
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A

Profitability

This table compares Adams Diversified Equity Fund and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Adams Diversified Equity FundN/AN/AN/A
Tekla Healthcare InvestorsN/AN/AN/A

Summary

Tekla Healthcare Investors beats Adams Diversified Equity Fund on 4 of the 4 factors compared between the two stocks.

PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Insider & Institutional Ownership

6.9% of PIMCO Corporate & Income Opportunity Fund shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

PIMCO Corporate & Income Opportunity Fund has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PIMCO Corporate & Income Opportunity Fund0000N/A
Tekla Healthcare Investors0000N/A

Dividends

PIMCO Corporate & Income Opportunity Fund pays an annual dividend of $1.56 per share and has a dividend yield of 8.3%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. PIMCO Corporate & Income Opportunity Fund has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Valuation and Earnings

This table compares PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PIMCO Corporate & Income Opportunity FundN/AN/AN/AN/AN/A
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A

Profitability

This table compares PIMCO Corporate & Income Opportunity Fund and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PIMCO Corporate & Income Opportunity FundN/AN/AN/A
Tekla Healthcare InvestorsN/AN/AN/A

Summary

Tekla Healthcare Investors beats PIMCO Corporate & Income Opportunity Fund on 3 of the 4 factors compared between the two stocks.

Goldman Sachs BDC (NYSE:GSBD) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

Valuation and Earnings

This table compares Goldman Sachs BDC and Tekla Healthcare Investors' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Goldman Sachs BDC$147.26 million13.38$36.15 million$1.989.79
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A

Goldman Sachs BDC has higher revenue and earnings than Tekla Healthcare Investors.

Profitability

This table compares Goldman Sachs BDC and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Goldman Sachs BDC9.56%11.79%4.83%
Tekla Healthcare InvestorsN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for Goldman Sachs BDC and Tekla Healthcare Investors, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Goldman Sachs BDC02102.33
Tekla Healthcare Investors0000N/A

Goldman Sachs BDC presently has a consensus target price of $15.9167, suggesting a potential downside of 17.91%. Given Goldman Sachs BDC's higher probable upside, analysts clearly believe Goldman Sachs BDC is more favorable than Tekla Healthcare Investors.

Insider & Institutional Ownership

13.8% of Goldman Sachs BDC shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 0.3% of Goldman Sachs BDC shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Dividends

Goldman Sachs BDC pays an annual dividend of $1.80 per share and has a dividend yield of 9.3%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Goldman Sachs BDC pays out 90.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Goldman Sachs BDC has increased its dividend for 1 consecutive years and Tekla Healthcare Investors has increased its dividend for 1 consecutive years.

Risk & Volatility

Goldman Sachs BDC has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500.

Summary

Goldman Sachs BDC beats Tekla Healthcare Investors on 8 of the 11 factors compared between the two stocks.

Hercules Capital (NYSE:HTGC) and Tekla Healthcare Investors (NYSE:HQH) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Earnings and Valuation

This table compares Hercules Capital and Tekla Healthcare Investors' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hercules Capital$267.87 million7.29$173.60 million$1.4111.99
Tekla Healthcare InvestorsN/AN/AN/AN/AN/A

Hercules Capital has higher revenue and earnings than Tekla Healthcare Investors.

Profitability

This table compares Hercules Capital and Tekla Healthcare Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hercules Capital42.72%13.58%6.31%
Tekla Healthcare InvestorsN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for Hercules Capital and Tekla Healthcare Investors, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hercules Capital00803.00
Tekla Healthcare Investors0000N/A

Hercules Capital currently has a consensus price target of $13.8438, suggesting a potential downside of 18.08%. Given Hercules Capital's higher probable upside, equities analysts clearly believe Hercules Capital is more favorable than Tekla Healthcare Investors.

Insider and Institutional Ownership

28.9% of Hercules Capital shares are held by institutional investors. Comparatively, 22.2% of Tekla Healthcare Investors shares are held by institutional investors. 3.3% of Hercules Capital shares are held by insiders. Comparatively, 7.3% of Tekla Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Dividends

Hercules Capital pays an annual dividend of $1.28 per share and has a dividend yield of 7.6%. Tekla Healthcare Investors pays an annual dividend of $1.89 per share and has a dividend yield of 7.8%. Hercules Capital pays out 90.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Hercules Capital has raised its dividend for 1 consecutive years and Tekla Healthcare Investors has raised its dividend for 1 consecutive years.

Volatility and Risk

Hercules Capital has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. Comparatively, Tekla Healthcare Investors has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Summary

Hercules Capital beats Tekla Healthcare Investors on 8 of the 11 factors compared between the two stocks.


Tekla Healthcare Investors Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DNP Select Income Fund logo
DNP
DNP Select Income Fund
1.2$10.16+0.7%$3.12 billionN/A0.00Decrease in Short Interest
NUV
Nuveen Municipal Value Fund
0.7$11.37+0.2%$2.36 billionN/A0.00News Coverage
ADX
Adams Diversified Equity Fund
0.7$19.01+0.2%$2.11 billionN/A0.00Upcoming Earnings
PTY
PIMCO Corporate & Income Opportunity Fund
0.8$18.69+0.3%$1.98 billionN/A0.00
Goldman Sachs BDC logo
GSBD
Goldman Sachs BDC
1.4$19.39+0.0%$1.97 billion$147.26 million64.63
Hercules Capital logo
HTGC
Hercules Capital
1.5$16.91+0.1%$1.95 billion$267.87 million15.66
RVT
Royce Value Trust
1.0$18.67+0.5%$1.87 billionN/A0.00Increase in Short Interest
News Coverage
The Gabelli Equity Trust logo
GAB
The Gabelli Equity Trust
0.8$6.97+0.4%$1.83 billionN/A0.00
Tri-Continental logo
TY
Tri-Continental
0.9$33.45+0.3%$1.80 billionN/A0.00
Liberty All-Star Equity Fund logo
USA
Liberty All-Star Equity Fund
1.2$8.24+0.2%$1.75 billionN/A0.00Dividend Increase
Decrease in Short Interest
News Coverage
Liberty All-Star Equity Fund logo
USA
Liberty All-Star Equity Fund
0.9$8.24+0.2%$1.75 billionN/A0.00Dividend Increase
Decrease in Short Interest
News Coverage
Tortoise Energy Infrastructure logo
TYG
Tortoise Energy Infrastructure
0.7$25.59+2.4%$1.34 billionN/A0.00Increase in Short Interest
News Coverage
BIF
Boulder Growth & Income Fund
0.8$13.15+0.1%$1.29 billionN/A0.00
QQQX
Nuveen Nasdaq 100 Dynamic Overwrite Fund
0.3$28.24+0.6%$1.18 billionN/A0.00Decrease in Short Interest
News Coverage
AWF
AllianceBernstein Global High Income Fund
0.8$11.96+0.0%$1.03 billionN/A0.00Decrease in Short Interest
GAM
General American Investors
0.8$41.56+0.0%$1.02 billionN/A0.00Decrease in Short Interest
News Coverage
MYI
BlackRock MuniYield Quality Fund III
0.8$14.34+0.2%$979.32 millionN/A0.00Increase in Short Interest
Apollo Investment logo
AINV
Apollo Investment
1.2$14.16+0.1%$925.37 million$276.92 million-8.53Decrease in Short Interest
VMO
Invesco Municipal Opportunity Trust
0.9$13.43+0.7%$899.25 millionN/A0.00Decrease in Short Interest
PHK
PIMCO High Income Fund
0.9$6.81+0.6%$894.41 millionN/A0.00
SLR Investment logo
SLRC
SLR Investment
1.9$18.81+1.3%$805.48 million$154.71 million-156.75
TDF
Templeton Dragon Fund
1.0$22.45+0.1%$757.89 millionN/A0.00Increase in Short Interest
News Coverage
VGM
Invesco Trust for Investment Grade Municipals
1.0$13.73+0.1%$745.59 millionN/A0.00Decrease in Short Interest
BTO
John Hancock Financial Opportunities Fund
1.2$39.47+0.8%$734.10 millionN/A0.00Increase in Short Interest
VKQ
Invesco Municipal Trust
0.8$13.30+0.5%$732.44 millionN/A0.00Increase in Short Interest
GIM
Templeton Global Income Fund
1.1$5.39+0.7%$728.40 millionN/A0.00News Coverage
MYD
BlackRock MuniYield Fund
0.9$14.73+0.1%$690.66 millionN/A0.00Decrease in Short Interest
Invesco California Value Municipal Income Trust logo
VCV
Invesco California Value Municipal Income Trust
0.8$13.14+0.7%$624.70 millionN/A0.00Decrease in Short Interest
News Coverage
MUC
BlackRock MuniHoldings California Quality Fund
0.3$15.08+0.1%$617.90 millionN/A0.00
MVF
BlackRock MuniVest Fund
0.3$9.41+0.4%$612.74 millionN/A0.00Decrease in Short Interest
News Coverage
MMU
Western Asset Managed Municipals Fund
0.9$13.20+0.2%$572.46 millionN/A0.00Decrease in Short Interest
IFN
The India Fund
0.8$20.96+0.2%$565.11 millionN/A0.00Decrease in Short Interest
MFL
BlackRock MuniHoldings Investment Quality Fund
0.7$14.68+0.9%$551.39 millionN/A0.00Decrease in Short Interest
MUA
BlackRock MuniAssets Fund
0.9$15.19+0.7%$547.48 millionN/A0.00Increase in Short Interest
EVN
Eaton Vance Municipal Income Trust
0.8$13.77+0.1%$545.42 millionN/A0.00Increase in Short Interest
News Coverage
LEO
BNY Mellon Strategic Municipals
0.7$8.65+1.2%$544.25 millionN/A0.00Increase in Short Interest
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
0.8$14.41+0.4%$540.93 millionN/A0.00Decrease in Short Interest
BlackRock MuniYield New York Quality Fund logo
MYN
BlackRock MuniYield New York Quality Fund
0.9$13.68+0.5%$538.78 millionN/A0.00Decrease in Short Interest
DSU
BlackRock Debt Strategies Fund
0.8$11.11+0.1%$519.68 millionN/A0.00Increase in Short Interest
News Coverage
MCA
BlackRock MuniYield California Quality Fund
0.8$14.96+0.2%$515.75 millionN/A0.00Decrease in Short Interest
News Coverage
RMT
Royce Micro-Cap Trust
1.2$11.77+0.4%$509.43 millionN/A0.00Increase in Short Interest
News Coverage
BBH
VanEck Vectors Biotech ETF
0.5$180.28+0.9%$508.75 millionN/A0.00News Coverage
DSM
BNY Mellon Strategic Municipal Bond Fund
0.9$8.04+0.7%$503.90 millionN/A0.00Increase in Short Interest
MQY
BlackRock MuniYield Quality Fund
0.8$16.11+0.3%$493.28 millionN/A0.00
PPT
Putnam Premier Income Trust
0.8$4.74+0.2%$490.30 millionN/A0.00
KTF
DWS Municipal Income Trust
0.8$11.87+0.0%$468.88 millionN/A0.00Dividend Announcement
Decrease in Short Interest
PMO
Putnam Municipal Opportunities Trust
0.8$13.88+1.1%$468.33 millionN/A0.00
MUJ
BlackRock MuniHoldings New Jersey Quality Fund
0.8$15.12+0.1%$455.52 millionN/A0.00
MIY
BlackRock MuniYield Michigan Quality Fund
0.9$15.21+0.1%$448.85 millionN/A0.00
HQL
Tekla Life Sciences Investors
0.9$19.71+0.9%$444.73 millionN/A0.00Increase in Short Interest
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.